Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Cash-and-Short-Term-Investments" stands at 20.45 Billion Japanese Yens as of 06/30/2025, the lowest value at least since 12/31/2010, the period currently displayed.
As of the end of Sumitomo Dainippon Pharma Co Ltd's first quarter, the item "Cash and Short Term Investments" stands at 20.45 Billion JPY. This represents a decrease of -48.81 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -73.91 percent compared to the value the year prior.
The 1 year change in percent is -73.91.
The 3 year change in percent is -92.30.
The 5 year change in percent is -82.54.
The 10 year change in percent is -86.58.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Short Term Investments | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Short Term Investments | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Short Term Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Short Term Investments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Short Term Investments | 280,205,508,085.11 |